© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
April 2nd 2021, 9:00pm
Previously, Vidaza alone showed poor response rates for patients with TP53-mutated, myelodysplastic syndromes and acute myeloid leukemia, but adding the novel agent eprenetapopt improved response rates and overall survival in this patient population.
December 17th 2020, 5:00am
July 28th 2020, 8:00pm
Before I became ill, I had wondered why anyone would want to work in a field where they knew people might die. But after meeting some incredible nurses during my cancer journey, I now know why.
July 8th 2020, 12:07am
The Food and Drug Administration approved the oral combination of Inquovi (Dacogen [decitabine] and cedazuridine) for certain adult patients with myelodysplastic syndromes (MDS).
May 24th 2020, 10:00pm
A cancer survivor describes the changes of going for treatment during the pandemic.
February 15th 2020, 8:00pm
A cancer survivor often contemplates which is the lesser of two evils – cancer or treatment?
December 4th 2019, 10:00pm
What do erasers, drawings, cancer and life all have in common? More than you might think.
October 23rd 2019, 8:00pm
Sometimes starting a new chapter in life can be good for cancer survivors.
October 3rd 2019, 8:00pm
Every cancer survivor has days when negative thoughts take over. Why not use visualization of video games to get rid of the self-defeating ideas?
September 23rd 2019, 8:00pm
Just when a patient with cancer is ready to throw in the towel is often when the tide turns.
Traveling Amid the COVID-19 Pandemic As A Cancer Survivor
The Definition of ‘Extraordinary’
Oncology Nurses Make ‘the Most Difficult Situation … Much Easier’
Immunotherapy Could “Provide A Whole New Realm” For Patients with Myeloma